Table 2.
Validation cohort 1: clinical characteristics of patients for tissue microarray experiment
| Patients | Number (%) | |
|---|---|---|
| Number | 170 | |
| Age (years), mean (range) | 52 (39–93) | |
| Histology | Serous | 150 (88.2) |
| Non serous | 20 (11.8) | |
| Stage | I | 7 (4.1) |
| II | 11 (6.4) | |
| III | 129 (72.9) | |
| IV | 21 (12.3) | |
| Grade | 1 | 6 (3.5) |
| 2 | 22 (12.9) | |
| 3 | 136 (80) | |
| Chemotherapy | Neo-adjuvant | 85 (50) |
| Adjuvant | 85 (50) | |
| Residual disease | ≤1 cm | 87 (51.2) |
| ≥1 cm | 57 (33.5) | |
| Not determined | 26 (15.3) | |
| Response | Responsive | 123 (72.3) |
| Resistant | 47 (27.7) | |
| Recurrence | Number | 128 (75.3) |
| Mean time (range) | 20 months (2–76) | |
| Deceased | Number | 105 (61.8) |
| Mean time (range) | 47 months (2–156) | |
| Follow up | Mean time (range) | 43 months (2–73) |